Author:
Yin Xin,Zheng Zixuan,Dong Yue,Li Junqing,Yang Shuang,Xu Qian,Hou Shanshan,Zang Yi,Ding Heyuan,Xie Juan,Jie Zhijun,Jiang Qingwu,Shi Jindong,Wang Na
Abstract
BackgroundTo compare whether the general population, especially those without characteristic symptoms, need spirometry screening for chronic obstructive pulmonary disease (COPD).MethodsResidents aged > 40 years old in Minhang, Shanghai, China, filled out screening questionnaires and underwent spirometry. The structured questionnaire integrating COPD population screening and COPD screening questionnaire was designed to obtain data on demographic characteristics, risk factors of COPD, respiratory symptoms, lifestyle habits, and comorbidities. We assessed the correlations between variables and COPD and the impact factors of FEV1% predicted.ResultsA total of 1,147 residents were included with a newly diagnosed mild to moderate COPD prevalence of 9.4% (108/1,147); half of the patients (54/108) were asymptomatic. Multivariate analysis did not reveal any significant differences in symptoms or lifestyle factors between newly diagnosed COPD patients and non-COPD participants. However, according to the generalized linear model, older age (β = −0.062, p < 0.001), male sex (β = −0.031, p = 0.047), and respiratory symptoms (β = −0.025, p = 0.013) were associated with more severe airflow limitation.ConclusionNewly diagnosed COPD patients had few differences compared with the general population, which suggests that a targeted case finding strategy other than general screening was currently preferred. More attention should be paid to respiratory symptoms when making a diagnosis and exploring new therapies and interventions for COPD in the early stage.
Subject
Public Health, Environmental and Occupational Health
Reference37 articles.
1. RenoGOLDGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2022 Report
2. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study;Wang;Lancet.,2018
3. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015;GBD;Lancet Respir Med,2017
4. Global burden of chronic respiratory diseases;Viegi;J Aerosol Med Pulm Drug Deliv.,2020
5. Early detection, early diagnosis and early intervention: the main research direction for the prevention and treatment of chronic obstructive pulmonary disease in China;Zhong;Zhonghua Jie He He Hu Xi Za Zhi.,2012